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Spasticity is defined as an increase in muscle tone that is elicited 
by a velocity-dependent stretching of the muscles. It is part of the 
upper motor neuron syndrome of muscle weakness and is worst in 
antigravity muscles.[1,2] The most common causes of spasticity are:
• cerebral palsy (spasticity is a dominant feature in 80% of all 
patients with cerebral palsy)[3]
• stroke
• traumatic brain injury 
• spinal cord injury
• multiple sclerosis
• hereditary spastic paraparesis
• degenerative neuromuscular diseases.
Management of spasticity should follow a planned, stepwise process 
of gradual escalation of therapy; only when the preceding step is 
shown to be ineffective, should more invasive options be considered. 
It is especially important to remember that the presence of spasticity 
in itself is not an indication for surgical management − only when 
spasticity becomes troublesome does surgery become an option. 
Criteria used to consider surgical management options are:
• spasticity that impairs function in a patient, e.g. difficulty with walking 
owing to spastic hamstring muscle group and triceps surae muscles
• spasticity that causes significant pain to the patient
• spasticity that makes caring for the patient troublesome, e.g. 
adductor spasticity, which makes it difficult to change a child’s 
nappy; or a debilitated stroke patient
• spasticity may lead to irreversible deformities of the skeletal system, 
such as hip dislocations or abnormal degeneration of hip and knee 
joints owing to asymmetrical weight-bearing on the joints.
Pathophysiology of spasticity
Over the past century there has been little progress in the under-
standing of the pathogenesis of spasticity. Concepts developed by 
Sherrington[4] in his Nobel prize-winning work in 1932 still hold true 
today. Sherrington described the concept of reciprocal innervation 
and noted that the muscle is under inhibitory and excitatory control 
of the central nervous system. Key to his understanding of spasticity 
was loss of this control owing to injury to the spinal cord or brain. 
Loss of inhibitory control from the brain via the spinal cord leads to 
uninhibited excitation of the monosynaptic spinal reflex arc.[5] The 
muscles, therefore, fire on their own, which causes spasticity. A basic 
representation of this reflex arc is shown in Fig. 1. 
Inhibition of the corticospinal tract is generally thought to 
cause spasticity, but over the years it has been noted that there are 
many examples of corticospinal tract injuries where patients do 
not present with spasticity, but reduced tone. It is thought that the 
reticulospinal tract, which has a modulation effect via interneurons 
on the afferent signal to muscles, may play a more significant role 
Surgical management of spasticity
J M N Enslin,1 BPhysT, MB ChB, FCNeurosurgery (SA), MMed (Neurosurg); A G Fieggen,2 MB ChB, MSc, MD, FCNeurosurgery (SA)
 
1  Division of Neurosurgery, Red Cross War Memorial Children’s Hospital, and Constantiaberg Mediclinic, Cape Town, South Africa
2  Department of Neurosurgery, Faculty of Health Sciences, University of Cape Town, and Division of Neurosurgery, 
  Red Cross War Memorial Children’s Hospital, Cape Town, South Africa
Corresponding author: J M N Enslin (enslin@functionalneurosurgery.co.za)
The management of patients with cerebral palsy and other causes of spasticity is a challenge to an entire rehabilitation team and to care givers. In 
South Africa, neurosurgeons have had limited involvement in this field owing to a perceived lack of options, leaving the care of these patients 
largely in the hands of paediatric neurologists and orthopaedic surgeons. A committed team-based approach, where a neurosurgeon is part 
of the decision-making process, can however significantly improve functional outcomes in patients with spasticity. Key to the evaluation 
and therapeutic decision-making is the focus on function – not only the range of movement or the presence of spasticity. Some techniques 
can completely remove spasticity and contractures, but these mostly leave a patient with more functional impairment than they had before 
the surgery. With the careful combination of botulinum toxin injections and oral baclofen, these patients, who may benefit from further 
orthopaedic and neurosurgical procedures, can be identified and helped in reducing the function-limiting spasticity. With the emphasis 
on function as an individualising factor, significant improvements may follow minor interventions, e.g. performing a surgical procedure to 
allow reduced hip adductor spasticity, thereby allowing improved hygiene and less pain in a child in whom it was previously not possible 
to abduct the hips enough to change a nappy. Functional improvement does not necessarily equate to walking. We describe the process of 
evaluating patients with spasticity and outline the surgical decision-making process that helps towards an individualised therapeutic strat-
egy in managing this challenging group of patients.
S Afr Med J 2016;106(8):753-756. DOI:10.7196/SAMJ.2016.v106i8.11225
Spinal cord
Dorsal nerve root
Skeletal muscle
Ventral nerve root
Fig. 1. Schematic illustration of monosynaptic spinal reflex.
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in the pathogenesis of spasticity, and loss of reciprocal inhibition 
after spinal cord injuries or cerebral injuries may lead to spasticity.[5] 
From the many theories of the causes of spasticity in humans, 
it is clear that we do not completely understand the condition. As 
diagnostic tests and more qualitative evaluation techniques become 
available, we may get closer to the answers.
Evaluation of spasticity for surgical 
management 
The surgical management of spasticity should focus on the functional 
evaluation of the patient. Meticulous questioning and evaluation of 
the patient during their daily activities and of their lifestyle is much 
more revealing than the most thorough neurological examination. The 
approach to taking the history and examining the patient should reflect 
this. It is invaluable to evaluate a patient in their home environment. A 
video recording taken by a relative of the patient sitting in a chair, lying 
on the bed, standing and walking is also of great benefit. This allows 
one to assess function in a familiar environment. Careful observation 
of the patient while the family, or the patient, recounts the history is 
often much more beneficial than a physical examination. 
The following points are important to observe in the history:
• antenatal events and maternal health
• perinatal events, such as hypoxia, prolonged labour, premature 
rupture of the membranes, HIV exposure, Apgar scores
• family history of neurological diseases
• trauma 
• previous operations for spasticity or orthopaedic deformities or 
corrections
• current and previous medications
• intervals of botulinum toxin injections and splinting, if any.
A detailed systemic history with specific attention to bladder and 
bowel habits is also important. One needs to enquire about respiratory 
tract infections, as patients with cerebral palsy are more prone to such 
infections. Throughout the examination, careful attention should 
be paid to determine whether the problematic spasticity is focal 
or diffuse, and whether there are dystonic features associated with 
or underlying the spasticity. The latter has significant therapeutic 
implications. 
Physical examination of patients with spasticity should be inititated 
by evaluating function:
• eating or drinking, dressing and communicating while sitting
• standing upright from a seated position on own wheelchair, a chair 
or a bed
• balancing in standing and sitting positions
• gait with and without support or frames
• gait and standing with and without an orthosis 
• ability to climb stairs 
• running and jumping (if possible).
Once these functional activities have been evaluated, the focus should 
move towards more specific aspects of spasticity:
• Posture when lying, sitting and standing is important – note pelvic 
alignment and spinal deformities.
• Trunk and neck tone while sitting and standing.
• Muscle power in a functional motion, such as kneeling, sitting, 
squatting, and climbing a step. Traditional measures of power are 
not reliable in a patient with abnormal tone.
• Range of motion in all joints, especially around the hips and ankles.
• Evaluation of muscle tone, as spasticity is a velocity-dependent 
increase in tone. Pay attention to the difference between active and 
passive movements and tone.
• With regard to deep tendon reflexes, pay specific attention to crossing 
over of reflexes to other limbs as well as spreading of reflexes in the 
same limb.
• Presence of pathological reflexes, such as clonus and the Babinski sign.
• A good screening sensory examination that focuses on proprio-
ception and light touch is important for future surgical inter-
ventions.
• Establish whether the spinal deformity has been corrected or is 
correctable.
Management of spasticity
Spasticity in itself is not a problem; its presence may be protective in 
preventing the patient from further injuring a limb or joint, especially 
in focal spasticity, which occurs after a stroke in an upper limb. The 
presence of spasticity may increase the functional abilities in some 
patients, e.g. children with spastic diplegia may be able to stand, 
because they may use their hip adductor spasticity to increase truncal 
tone, which forms a stable base for them to stay erect.
Once spasticity leads to pain and deformities or it starts to impair 
function, treatment to reduce it becomes important. In the evaluation 
of spasticity the clinician must decide whether it is focal or diffuse/
global. Fig. 2 demonstrates how this important differentiation is 
used to decide which therapeutic modality is potentially useful. 
There is, for example, no place for the use of intrathecal baclofen in 
patients with focal hand spasticity. It is also not possible to administer 
botulinum toxin injections or perform a peripheral neurotomy on 
every muscle involved in diffuse spasticity, such as in a child with 
spastic quadriplegia.
Physical and occupational therapy remain at the core of any good 
rehabilitation and care programme for all patients with spasticity. 
Speech therapists and psychology services also have an important 
role in the holistic care plan. The entire team must understand the 
functional goals of surgery, and often training that starts ahead of 
surgery is extremely beneficial in optimising the patient for the 
procedure, but also in learning new exercises that follow the surgery.
The various surgical treatments for patients with function-limiting 
spasticity are listed in Table 1. As a rule, most patients with spasticity 
should be on oral baclofen as an empiric antispasticity medication. 
If pain forms a major part of the spasticity, either as an exacerbation 
factor or owing to the spasticity, pain-modulating medications that 
also have an effect on spasticity, such as gabapentin, may be added. 
Once these non-surgical management options have been exhausted, 
with no improvement in the function of the patient, surgical manage-
ment may become relevant. 
Botulinum
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Fig. 2. Spasticity management diagram.
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Selective peripheral neurotomy. The peripheral nerve is dissected 
free and the motor branches are mapped out with the use of a 
nerve stimulator. Once absence of a sensory branch of the nerve is 
confirmed, about 80% of the nerve to the spastic muscle is sectioned 
and 5 mm are resected. The goal is to restore the balance between 
the agonist and antagonist muscles around a joint. It is therefore 
only appropriate for focal spasticity around one or two joints, e.g. a 
hemiplegic patient after a stroke, who is starting to stand but cannot 
stand on a flat foot owing to inversion of the foot, resulting in pain. 
Performing a peripheral neurotomy on the posterior tibial nerve, 
targeting the branches to the tibialis posterior muscle, can allow the 
patient to stand on a flat foot with less pain. The muscle is usually 
not perceived to be weaker, as the number of motor units innervated 
by the remaining nerve fascicles increases significantly within a few 
weeks and there should not be any discernable sensory deficit after 
the procedure. 
Baclofen. This acts as a gamma-aminobutyric acid  (GABA) 
β-receptor agonist, leading to a reduction in calcium inflow to nerve 
terminals and a reduction in excitation in neurotransmitters that are 
released in the spinal cord.[6] While baclofen can be administered 
orally, the side-effects are often not tolerated and an attractive alter-
native is direct administration. 
Intrathecal baclofen (ITB). This is provided by an implanted 
pump. A small catheter is placed into the thecal space (subarachnoid 
spinal canal), with the tip placed in the high cervical area to treat 
dystonia or spastic quadriplegia, or in the low thoracic area to 
treat spastic diplegia. Baclofen can then be administered in a slow 
continuous infusion at a much lower dose than oral baclofen. This 
leads to better bioavailability at the receptors in the spinal canal and 
fewer systemic effects. A key benefit of ITB is that it is reversible and 
very effective in patients with dystonia and spasticity.
Selective dorsal rhizotomy. This is a surgical procedure that is well 
proven in children with spastic diplegia and was adopted worldwide 
following Warwick Peacock’s work in Cape Town in the 1980s. 
During this procedure, a multilevel laminotomy is performed from 
the L2 - S1 level, the cauda equina is exposed and the dorsal root is 
separated from the ventral root. The dorsal root is then split, typically 
into 3 - 4 fascicles, and guided by intraoperative neurophysiology, 
between 30% and 60% of the dorsal root being sectioned. With the 
use of this technique the monosynaptic reflex arc is interrupted, 
which reduces the spasticity. Key to this operation is good strength 
and postural stability in the child before surgery is considered. Pelvic 
control and strength of hip extension and abduction with good knee 
extension are very important in rehabilitation and improving gait in 
these patients. 
Dorsal root entry zone lesioning (DREZotomy). During this 
procedure the point where the dorsal nerve roots enter the spinal cord 
is cauterised up to a specific depth. This interupts the interneurons 
for muscle tone in the Rexed laminar levels. The great benefit of this 
procedure is that it can be done selectively and for multiple levels, 
depending on the individual’s need. DREZotomy is also an excellent 
operation for pain; with the correct technique a patient with severe 
pain due to uncontrolled spasticity may obtain significant relief of 
both. 
The techniques discussed above are mostly irreversible (Fig. 2). It is 
therefore very important to determine what the expected functional 
effect of a procedure will be. Muscle tone is lower after surgery, but one 
also needs to have a concept of the patient’s function afterwards. For 
example, it is not helpful to have improved leg tone but be unable to 
stand or walk if one could do this before the procedure. The expected 
effect can be tested by using botulinum toxin in selective muscles, 
temporarily administering ITB via an infusion pump, or performing 
a peripheral nerve block with a long-acting neural anaesthetic 
agent. Functional activity can now be evaluated with the temporary 
reduction in muscle tone. Reliable intraoperative neurophysiology is 
mandatory during surgical techniques for spasticity. These techniques 
are used to preserve bladder and bowel function and to guide 
fascicular dissection. 
Surgery forms a small part of the entire process involved in man-
aging patients with spasticity. As illustrated in Fig. 3, careful evalu-
ation and appropriate surgical procedures, performed with the cor-
rect goal in mind, need to be followed by active patient and family 
participation in a structured rehabilitation programme that starts 
as soon as possible after surgery. The goals of the patient, therapist, 
relatives, caregivers and surgeon all need to be aligned and specific 
functional activities developed that will improve certain aspects of 
the recovery and rehabilitation process. There is no one recipe that 
fits all patients.
Outcomes of surgery for spasticity
Clear goals need to be discussed with the family and the manage-
ment team before surgery. Expectations need to be tailored to 
what is achievable. It is not possible, for example, for a child who is 
completely dependent for all daily activities (gross motor function 
classification system (GMFCS) level 5) to walk independently after 
any form of surgical therapy. Any surgeon claiming this possibility is 
headed for a disaster. 
The goal of surgical therapy may not necessarily be for the patient 
to walk independently. A realistic goal for a 65-year-old woman with 
left hemiplegia after a stroke may be to be able to hold a glass of 
water with her left hand again, or to stand with a flat foot while using 
a walking stick. A surgical goal in a spastic quadriplegic child who is 
wheelchair bound, may be for the child to be able to lie down flat on 
his back in bed while asleep, without hips and knees pulling up into 
flexion continuously. This reduction in spasticity around the hips 
may allow improved personal care and reduced bladder infection, 
Table 1. Surgical options in patients with spasticity
Neurosurgical Other surgical
Selective peripheral neurotomy Tendon-lengthening procedures
Intrathecal baclofen therapy Bony anatomy correction/
rotation osteotomies
Selective dorsal rhizotomy Intravesicular botulinum toxin 
injections
Dorsal root entry zone lesioning Intramuscular botulinum toxin 
injections
Evaluation
Surgery
Rehabilitation
Fig. 3. The importance of evaluation and rehabilitation in spasticity manage­
ment.
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as the hips can now be abducted to allow easier nappy changes and 
cleaning. Improving the ability for a wheelchair-bound child to sit 
more easily in a wheelchair with comfortable knee and hip flexion is 
also a great achievement in a severely spastic child who has difficulty 
being placed in a wheelchair owing to severe hip and knee spasticity. 
At the same time, it is possible for a child with spastic diplegia to walk 
unaided after a selective dorsal rhizotomy if he has good trunk and 
hip strength. Small improvements on a rating scale may lead to large 
functional gains in a patient.
The preoperative goals of surgery should be clearly defined by 
the family and the rehabilitation team. The outcome should be 
functional; this same function should be targeted in personalising 
the therapeutic strategy and the postoperative outcomes evaluation. 
ITB shows very good reduction in spasticity and painful deformi-
ties caused by this condition in 80 - 97% of cases.[7] The reduction 
in spasticity is documented with a 2 - 3-point improvement in the 
5-point Ashworth scale, and tolerance is generally very good.[7] 
Peripheral neurotomies have an 80 - 85% success rate in reducing 
painful deformities and spasticity in focal conditions.[7] This leads to 
improved functional activity and prevents worsening of deformities 
caused by increased tone. 
DREZotomy leads to a 70 - 82% decrease in spasticity, while at 
the same time relieving pain in paraplegic patients in up to 91% of 
cases.[7] 
A 20-year follow-up by the Cape Town group[8] shows very good 
long-term outcomes in patients after selective dorsal rhizotomy. 
In a group of 14 patients, all but one had long-term control of 
their spasticity and good functional improvement that lasted into 
adulthood.
Complications of surgery for 
spasticity
As the purpose of the surgical treatment of spasticity is to improve 
function, possible complications must be carefully considered. It is 
particularly important that a wheelchair-bound patient does not have 
‘useless hypotonia’ after surgery. Concerns about impaired bladder 
and bowel control, as well as spinal deformities, are also frequently 
raised.
Tsirikos[9] reviewed reports on the incidence of spinal deformities 
in the cerebral palsy population and found an incidence of 20 - 25%. 
Some studies report up to a 74% incidence in spastic quadriplegic 
patients;[10] it is important to keep this natural history in mind when 
considering surgical management of spasticity and its influence on 
spinal deformity. In the 20-year study by Langerak et al.[8] − to date 
the study with the longest duration − no patients experienced spinal 
deformity that required further surgery. 
Urological dysfunction among patients with spasticity, and 
especially the cerebral palsy group, is much more common than 
previously thought. Mobility, age, communication problems and 
spasticity of the detrusor muscle all play a role.[10] Murphy et al.[11] 
have an interest in cerebral palsy patients and bladder function; 
16.4% of their cohort showed spastic, hyperreflexic bladders on 
urodynamic testing. There were no bladder or bowel complications 
reported in the selective dorsal rhizotomy cohort in the Cape 
Town study.[8] Specific enquiry and examination, often with invasive 
urodynamic testing, are important in patients with cerebral palsy, 
as resultant recurrent urinary tract infections may lead to renal 
injury in the long run. Major leaps in surgical techniques, but more 
importantly in intraoperative neurophysiological monitoring, have 
allowed surgeons to reduce the incidence of all these complications.
Summary
Surgery plays an important role in the multimodal management of 
spasticity. While every patient with spasticity can be helped, not all 
require an operation. In cases where an operation may benefit the 
patient, it is not a one-procedure-for-all scenario. Only a team, which 
consists of a neurosurgeon, orthopaedic surgeon, developmental 
paediatrician and rehabilitation therapists, can offer each patient an 
objective opinion on therapeutic options. Thorough examination 
and multiple visits are key to planning a management strategy. The 
distribution of spasticity is important, as this has implications with 
regard to surgical management options, and every patient should 
be carefully screened for the presence of dystonia. Patients who 
do not respond well to surgical procedures for spasticity are often 
those in whom a coexistence of dystonia was missed. The role of 
the family and video analysis of the patient in their home and work 
environment are important in determining the patient’s functional 
impairment. These impairments have to be incorporated in the 
surgical and rehabilitation goals of the patient, as individualisation of 
the therapeutic plan is crucial. 
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